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Insufficient blood flow through end-resistance arteries leads to symptoms associated with peripheral vascular disease.
This may be caused in part by poor macrocirculatory inflow or impaired microcirculatory function. Dysfunction of the
microcirculation occurs in a similar fashion in multiple tissue beds long before the onset of atherosclerotic symptoms.
Impaired microcirculatory vasodilatation has been shown to occur in certain disease states including peripheral vascular
disease, diabetes mellitus, hypercholesterolemia, hypertension, chronic renal failure, abdominal aortic aneurysmal
disease, and venous insufficiency, as well as in menopause, advanced age, and obesity. Microcirculatory structure and
function can be evaluated with transcutaneous oxygen, pulp skin flow, iontophoresis, and capillaroscopy. We discuss the
importance of the microcirculation, investigative methods for evaluating its function, and clinical applications and review
the literature of the microcirculation in these different states. ( J Vasc Surg 2005;42:574-81.)Symptoms associated with peripheral arterial insuffi-
ciency—specifically, claudication, rest pain, and tissue
loss—are caused by a lack of blood flow in the nutritional
capillaries of the microcirculation that does not meet the
metabolic demand of the surrounding tissues. Small vessels
contribute a substantial portion to the vascular resistance
and are intricately involved in the sequelae of peripheral
vascular disease (PVD).1 Endothelial dysfunction in these
small vessels is an early marker of vascular disease and
predisposes to vasoconstriction, enhanced leukocyte adhe-
sion, platelet activation, and, ultimately, the development
of atherosclerosis.2
Microvascular dysfunction is a systemic process that
occurs in a similar fashion in multiple tissue beds through-
out the body.3 Identification of impaired microvascular
blood flow and vasoreactivity by noninvasive means can
lead to early identification of patients at risk for peripheral
vascular and coronary artery disease.4 Furthermore, it can
provide a quantitative assessment of the effects of a given
treatment.
METHODS FOR EVALUATING THE
MICROCIRCULATION
Blood flow in the microcirculation is composed of the
skin nutritional capillaries and thermoregulatory arterio-
venous (AV) shunts. The proportional contribution of
these two sources is different in glabrous and nonglabrous
skin. Twenty-five percent of glabrous skin blood flow
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574comes from nutritional capillaries and 75% fromAV shunts,
and it is therefore subject to wide fluctuations.5 Nongla-
brous skin does not possess AV shunts, and blood flow is
composed almost completely of nutritional capillaries.
Structural differences in skin blood vessel architecture
account for variations in blood flow between glabrous and
nonglabrous skin. Saad et al6 found that skin blood flow
decreased significantly in response to isometric exercise in
glabrous, but not nonglabrous, skin. These results suggest
that AV shunts in glabrous skin cause a more sustained
vasoconstrictor tone, which may increase the risk for the
sequelae of PVD in this region.
Themicrocirculation was first evaluated in the coronary
arteries, where it was shown that microcirculatory dysfunc-
tion was associated with an increased risk of coronary artery
disease. Dilatation of the coronary microvasculature can be
assessed by measuring coronary blood flow with a Doppler
velocity catheter. This invasive technique carries the risks
associated with angiography and is not well suited to mul-
tiple measurements over time. This led investigators to
evaluate other arterial beds because endothelial dysfunction
was thought to be a global process. Flow-mediated dilata-
tion of the brachial artery (macrocirculation) due to occlu-
sive hyperemia has been shown to have a close association
with coronary vasoreactivity.7 Flow-mediated dilatation
does not specifically evaluate the end-resistance arteries of
the microcirculation, requires an ultrasound technician,
and can have up to 25% day-to-day variability.2 The impor-
tance of small-vessel resistance for ulcer formation led to
the development of both invasive and noninvasive tech-
niques that could reliably quantify microcirculatory func-
tion (Table).
Transcutaneous oxygen tension. Transcutaneous
oxygen tension (TCpO2) has been an integral part of the
noninvasive assessment of microcirculatory blood flow
since the 1970s. TCpO2 quantifies oxygen molecules trans-
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transducer to more than 40°C. TCpO2 is limited because it
is time consuming and does not assess all ischemic regions
of the skin unless the probe is specifically placed on the
tissue in question.
Pulp skin blood flow. The pulp skin of the toes has a
high incidence of ulcer formation in atherosclerotic vascu-
lar disease because of its distal location, and this has led
researchers to examine its microcirculation. This can be
accomplished with laser Doppler fluxmetry or heat and/or
radioisotope washout methods.
Laser Doppler fluxmetry scans superficial tissue blood
perfusion without physical contact, dyes, or tracer ele-
ments, thus minimizing the influence on perfusion and the
risk of contamination, infection, or discomfort to the pa-
tient. Blood flow is measured as the flux of red blood cells
through both the subpapillary vascular bed, which contains
AV shunts, and the nutritional capillaries. It is simple to use
and can be performed over any area of skin in a minimal
amount of time.
To distinguish between the nutritional capillaries and
AV shunts in glabrous skin, researchers have used a combi-
nation of heat and xenon washout methods.8 Heat washout
determines the total microcirculatory blood flow in gla-
brous skin. A thermostatically controlled electrode is placed
on the pulp skin of a finger or toe and is heated 2°C to 10°C
above normal skin temperature. When the temperature
stabilizes, the electrode is turned off, and temperature is
measured until it returns to baseline. Skin blood flow is
calculated as the slope of the change in temperature vs time.
Radioisotope washout uses xenon 133 (133Xe) to mea-
sure the blood flow in capillaries. 133Xe is specific to the
nutritional capillaries because of its low diffusion coefficient
compared with heat. By subtracting the flow in the 133Xe
washout method from that of the heat washout method,
one can determine the contribution of blood flow from AV
Table. Techniques available for evaluating microcirculator
Variable
Transcutaneous
oxygen tension
Skin pulp
blood flow
Noninvasive Yes Yes
Tissue bed Skin 25% nutritional capilla
75% arteriovenous s
Technique Heat skin 40°C Heat and/or radioisot
washout
Vasodilator Heat Exercise
Output Quantity of oxygen
molecules transferred
through skin
Temperature change o
laser Doppler fluxm
Pros Widely available Distinguishes blood fl
nutritional capillarie
arteriovenous shunt
Cons Spot measurements do
not predict ischemia
elsewhere
Has not been correlate
with other tissue beshunts in glabrous skin.Vasoreactivity. Evaluation of vasoreactivity is accom-
plished by comparing blood flow in response to a vasodila-
tor with that in the resting state. The most commonly used
vasodilators are acetylcholine (endothelium-dependent)
and sodium nitroprusside (endothelium-independent).
Acetylcholine causes microcirculatory vasodilatation
through two mechanisms, both of which are dependent on
an intact endothelium. Furchgott and Zawadzki9 described
the first mechanism in 1980 when they elucidated that
acetylcholine directly binds muscarinic receptors on the
endothelium and causes the release of nitric oxide (Fig 1).
The nitric oxide then diffuses to the media, thus causing
relaxation of the vascular smooth muscle cells and conse-
quent vasodilatation. The second mechanism is called the
Lewis triple-flare response, or nerve axon reflex-mediated
vasodilatation, and is caused by the action of acetylcholine
on C-nociceptive fibers (Fig 2). Acetylcholine sensitizes the
C-nociceptive fibers; this augments the release of substance
P and calcitonin gene-related peptide. Calcitonin gene-
related peptide directly causes vasodilatation,10 and sub-
stance P causes a release of mast cell histamine. This indirectly
leads to vasodilatation and increased vascular permeability. 11
Sodium nitroprusside is a nitric oxide donor that causes
vasodilatation through an endothelium-independent mecha-
nism (Fig 1). At physiologic pH, nitric oxide dissociates
from nitroprusside, diffuses through the intima, and di-
rectly stimulates guanyl cyclase in the vascular smooth
muscle cells. The resultant increase in cyclic guanosine
monophosphate leads to vessel relaxation.
Iontophoresis is a noninvasive method that delivers
these vasoactive medications subdermally by using an elec-
tric potential difference (Fig 3). Microcirculatory flow can
be measured with either laser Doppler fluxmetry or single-
point laser probes. Vasoreactivity is calculated as the differ-
ence between the flow before and after iontophoresis.
Laser Doppler fluxmetry is quick and simple, has small
ucture and function
Iontophoresis Capillaroscopy
Yes Yes (light) and
no (dynamic)
Subpapillary plexus, nutritional
capillaries, nerve-axon reflex
Subpapillary plexus,
nutritional capillaries
Subdermal delivery of
vasodilator
Light microscopy or
fluorescent dye
dynamic capillaroscopy
Pharmacologic None
Single-point probes or laser
Doppler fluxmetry
Morphologic changes and
blood cell velocity
Simple, correlated with other
microvascular beds, isolates
nerve-axon reflex
Distinguishes subpapillary
plexus from nutritional
capillaries
Cannot distinguish
subpapillary plexus from
nutritional capillaries in
glabrous skin
Not widely available,
requires sophisticated
equipmenty str
ries,
hunts
ope
r
etry
ow of
s and
s
d
dscoefficients of variation, and evaluates only nutritional cap-
cGMP, cyclic guanosine monophosphate.
endothelium-dependent vasodilatation.
JOURNAL OF VASCULAR SURGERY
September 2005576 Abularrage et alillary blood flow when performed on nonglabrous skin.
Single-point laser probes can be used to distinguish the direct
and indirect (nerve axon reflex) endothelium-dependent re-
sponse to acetylcholine.
Capillaroscopy. Basic light microscopy can be used to
study skin capillaries in vivo, usually in the nail skin folds.
Skin capillaries in an area with a reduced microcirculation
change in structure, and it is possible to evaluate the
morphology and blood flow of the skin by microscopic
studies of these capillary changes.12
More recently, dynamic capillaroscopy with sophisti-
cated computer software programs has been used to mea-
sure microvascular dynamics, flow distribution, and perme-
ability. The addition of fluorescent dyes to dynamic
capillaroscopy enables clinicians to distinguish the micro-
vascular from the interstitial compartments and assess trans-
capillary diffusion.
Certain technical aspects of these techniques make
them cumbersome, including both the cost and availability
of the equipment.Moreover, patients frequently need to be
placed in the sitting position to ensure good blood filling of
the capillaries, which makes this less physiologically dy-
Fig 3. Iontophoresis setup. The chamber (small arrow) is at-
tached to the volar surface of the proximal forearm with the
single-point probes (arrowhead), and a grounding pad is applied to
the wrist. The laser Doppler scan can be seen at the top of the figure
(large arrow).Fig 1. Mechanism of endothelium-dependent (left) and
endothelium-independent (right) vasoreactivity. In endothelium-
dependent vasoreactivity, acetylcholine (AC) binds the endothelial
receptor, thus leading to an increase in intracellular calcium and
upregulation of endothelial nitric oxide synthase (eNOS). In
endothelium-independent vasoreactivity, nitroprusside releases ni-
tric oxide, which then diffuses to the vascular smooth muscle cell.
Both pathways converge in the vascular smooth muscle cell, where
nitric oxide increases the activity of guanyl cyclase and causes
vasodilatation. RBC, Red blood cell; NADPH, nicotinamide ade-
nine dinucleotide phosphate; NADP, oxidized nicotinamide ad-
enine dinucleotide phosphate; GTP, guanosine triphosphate;Fig 2. Mechanism of the Lewis triple-flare response (nerve axon
reflex). Pain caused by injury results in orthodromic signals to the
spinal cord and antidromic signals to C-nociceptive fibers. Release
of substance P and calcitonin gene-related peptide (cGRP) causesnamic.
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IN DIFFERENT DISEASE STATES
Peripheral vascular disease. Microcirculatory dys-
function in patients with PVD was shown as long ago as
1980 by Matsen et al.13 Significantly lower TCpO2 values
were found in the feet of patients with arterial insufficiency
compared with those of healthy controls. Cina et al14
examined the TCpO2 in patients with PVD and found a
greater decrease in the calves of patients with rest pain or
tissue loss compared with claudicants.
More recent examinations of pulp skin blood flow in
claudicants have confirmed this impairment of microcircu-
latory function. Midttun et al15 showed that claudicants
have increased pulp blood flow when the lower extremity is
placed in the dependent position compared with controls,
whereas blood flow through the nutritional capillaries is the
same. This can be attributed to impaired AV shunt function
in response to changes in orthostatic pressure leading to an
absence of the venoarteriolar axon reflex and an increase in
shunted blood flow.
Furthermore, surgical revascularization reverses this
microcirculatory dysfunction. Pulp skin blood flow when
the lower extremity is at the heart level has been shown to
be lower in claudicants before revascularization compared
with healthy controls.8 After surgery, pulp skin blood flow
increased by a factor of 1.79, thus abolishing the difference
between the two groups.
Lamah et al16 examined the ratio of perfused to total
skin capillaries in patients with PVD by using dynamic
capillaroscopy. They found a higher proportion of perfused
capillaries in the skin of patients with PVD compared with
controls. A close look at their data shows that this was due
to a decreased total number of capillaries in the PVDgroup.
Because they did not measure microcirculatory blood flow,
it is impossible to tell whether the increased percentage of
perfused capillaries resulted in increased perfusion of the
skin.
In a similar study, Bongard and Fagrell17 used a com-
bination of laser Doppler fluxmetry and dynamic capillaros-
copy to evaluate the microcirculation of patients with PVD.
Nutritional capillary blood cell velocity, evaluated by cap-
illaroscopy, was similar in both groups. Total blood flow,
evaluated by laser Doppler scan, was increased in patients
with PVD. Finally, postocclusive reactive hyperemia was
decreased in patients with PVD. They concluded that mi-
crocirculatory function was impaired in patients with PVD,
with increased but maldistributed blood flow.
Diabetes mellitus. Early descriptions of diabetes as an
occlusive small-vessel disease were later refuted but led
investigators to identify functional abnormalities of the
microcirculation. As such, much of what we know about
the microcirculation stems from research performed on
diabetic patients.
TCpO2measurements are decreased in diabetic patients
with PVD but are occasionally increased in diabetic patients
without macrocirculatory dysfunction.18 This is caused by
an increase in arteriolar shunting in the microcirculation.Studies using dynamic capillaroscopy have confirmed these
findings. Jörneskog et al found similar, but maldistributed,
total microcirculatory blood flow in diabetic patients com-
pared with controls.19 There was a decrease in the nutri-
tional capillary contribution to the total blood flow, with a
proportional increase in AV shunting in diabetic patients.
Insulin has a vasodilating effect through endothelium-
dependent mechanisms caused by the muscarinic agonist
methacholine chloride, but it has little effect on endothelium-
independent vasoreactivity. This suggests that the endothe-
lium is a target for insulin and not just a passive site for
transport.20 Endothelial insulin receptors may also be a site
for insulin resistance, because patients with non–insulin-
dependent type 2 diabetes have impaired endothelium-
dependent vasoreactivity.21
Microvascular vasoreactivity is impaired in diabetic pa-
tients, as well as healthy subjects with normal glucose
metabolism who are at risk for developing the disease.
Caballero et al22 compared microcirculatory vasoreactivity
among healthy controls, diabetic patients without PVD,
patients with impaired glucose tolerance, and normoglyce-
mic patients with a parental history of type 2 diabetes. Both
endothelium-dependent and -independent responses were
reduced in all three groups compared with controls.
Certain studies have compared vasoreactivity between
insulin-dependent and non–insulin-dependent diabetic pa-
tients. Both groups have an impaired endothelium-dependent
response to acetylcholine iontophoresis,23 whereas only
non–insulin-dependent diabetic patients have an impaired
endothelium-independent response to sodium nitroprus-
side.24
Diabetic microvascular dysfunction may be related to
the accumulation of advanced glycosylation end products, a
product of poly(adenosine diphosphate–ribose) polymerase.
Activation of poly(adenosine diphosphate–ribose) polymerase
and the resultant increase in advanced glycosylation end prod-
ucts occur in patients with type 2 diabetes and those at risk
for developing type 2 diabetes and are associated with
significant impairment in microvascular vasoreactivity.25,26
Diabetic microangiopathy is associated with a loss of
the normal venoarteriolar reflex that restricts arterial inflow,
increases precapillary resistance in the skin, and avoids an
excessive increase in capillary pressures upon standing.27
We compared laser Doppler fluxmetry after iontophoresis
between the forearm and the foot and found that the
endothelium-dependent and -independent vasodilatory re-
sponses of the foot cutaneous microcirculation were lower
than those of the forearm and progressively worsened from
healthy subjects to nonneuropathic diabetics to neuro-
pathic diabetics.28
As discussed previously, acetylcholine causes microcir-
culatory vasodilatation through two separate but synchro-
nous mechanisms. Hamdy et al29 used single-point laser
probes to measure the total vasodilatation due to acetylcho-
line iontophoresis and the relative contribution of the nerve
axon reflex. The nerve axon reflex accounted for 36% of the
total effect of acetylcholine in healthy patients and 29% in
diabetic patients without neuropathy. The total acetylcholine-
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to the nerve axon reflex were both significantly reduced in
diabetic patients with neuropathy. The percentage contri-
bution of the nerve axon response was 20% in diabetic
patients with neuropathy and PVD, 8% in diabetic patients
with neuropathy, and 5% in diabetic patients with Charcot
arthropathy. These results suggest that neuropathy renders
the diabetic foot functionally ischemic because of its inabil-
ity to increase blood flow in response to stress.
Finally, surgical revascularization plays a major role in
the treatment of diabetic ischemic foot ulcers. We have
examined cutaneous microvascular reactivity by using heat
and iontophoresis in neuropathic diabetic patients with
peripheral ischemia before and after surgical revasculariza-
tion and compared this with that of neuropathic diabetic
patients without PVD, nonneuropathic diabetic patients,
and healthy controls.30 The maximal hyperemic response
to heat and the endothelium-dependent vasodilatation to
acetylcholine improved after surgery but did not reach the
levels of healthy controls. Endothelium-independent vaso-
dilatation to sodium nitroprusside improved to the level of
nonneuropathic diabetic patients and healthy controls.
Also, the nerve axon reflex-mediated vasodilatation failed
to improve after surgery. We concluded that successful
revascularization was associated with an improvement but
not a complete normalization of endothelial cell and vascu-
lar smooth muscle cell function.
Hypercholesterolemia. The endothelium is abnor-
mal in patients with increased levels of low-density lipopro-
teins, paradoxically vasoconstricting in response to acetyl-
choline.31 Furthermore, both endothelium-dependent and
endothelium-independent vasoreactivity are impaired in
patients with hypercholesterolemia compared with healthy
controls.32,33
Algotsson34 found that increased levels of high-density
lipoproteins in young and middle-aged women were asso-
ciated with improved endothelium-dependent vasoreactiv-
ity and found a trend toward improved endothelium-
independent vasoreactivity. Both endothelium-dependent
and -independent vasoreactivity were negatively correlated
with increased triglycerides and total cholesterol/high-
density lipoprotein ratios. No differences were found in
elderly women or men, but this study was subject to small
numbers.
Treatment of hypercholesterolemia with statins reduces
ischemic cardiac events. Khan et al33 examined vasoreactiv-
ity before and after treatment with fluvastatin. Baseline
endothelium-dependent and -independent vasoreactivity
were impaired in patients with hypercholesterolemia and
PVD compared with healthy controls. Cholesterol levels
improved by 12 weeks and remained stable through 24
weeks. There were no significant changes in vasoreactivity
by 12 weeks, despite a significant improvement in choles-
terol levels. By 24 weeks, though, there was a significant
improvement in endothelium-independent vasoreactivity
in the patient group. They attributed the improved vasore-
activity to an effect of fluvastatin itself, rather than itscholesterol-lowering effects, because of the lack of im-
provement in cholesterol levels between weeks 12 and 24.
Other treatments for hypercholesterolemia are also as-
sociated with improved microvascular vasoreactivity. Sim-
vastatin and/or cholestyramine lipid-lowering therapy causes
improved endothelium-dependent and -independent vasodi-
latation.35 Cessation of this therapy was associated with a
rapid return of vascular dysfunction. Tetrahydrobiopterin
supplementation restored endothelial-dependent vasoreac-
tivity in patients with familial hypercholesterolemia.36 This
was most likely related to impaired nitric oxide activity and
increased oxygen radical formation due to deficiency of
tetrahydrobiopterin, an essential cofactor of nitric oxide
synthase.
Hypertension. Chronically increased blood pressure
is associated with the early development of atherosclerosis.
This has led researchers to try to identify early changes in
the microcirculation of patients with essential hyperten-
sion.
One of the first studies examining the effects of essential
hypertension on forearm venous occlusion plethysmography
of the microcirculation showed that endothelium-dependent
vasoreactivity was impaired compared with healthy controls. 37
There were no differences in baseline, or endothelium-
independent, flow.
Farkas et al38 assessed microvascular dysfunction in
essential hypertension by using iontophoresis and also
found that endothelium-dependent vasoreactivity was im-
paired compared with normotensive controls. Others have
not shown any effect of essential hypertension on forearm
microvascular vasoreactivity.39
Similar to microcirculatory dysfunction in nondiabetic pa-
tients at risk of developing diabetes, decreased endothelium-
dependent vasoreactivity can be found in normotensive
subjects with a family history of hypertension.40 This sug-
gests that genetics may play a key role in the development of
microcirculatory dysfunction associated with essential hy-
pertension.
End-stage renal disease. End-stage renal disease is
associated with decreased arterial elasticity and vascular wall
damage. Cupisti et al41 have shown that renal failure,
independent of arterial hypertension, does not cause endo-
thelial dysfunction. They found that microvascular vasoreac-
tivity was not impaired in patients with end-stage renal disease
in the absence of hypertension. In a similar study, the same
group evaluated the effects of hemodialysis on the micro-
circulation.42 Endothelium-dependent and -independent
vasoreactivity were both impaired in patients who undergo
hemodialysis compared with end-stage renal disease pa-
tients being treated conservatively. These results did not
improve immediately after a hemodialysis session, thus
suggesting that chronic uremia causes the vascular changes
associated with chronic renal failure.
Abdominal aortic aneurysms. Disorganization and
disruption of elastic fibers in the tunica media of the infra-
renal abdominal aorta is a hallmark of aneurysmal disease.43
Examination of the pulp skin blood flow in patients with
abdominal aortic aneurysmal disease has alluded to the
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lar component. Midttun et al44 found that the capillary
blood flow rate was higher in the adipose tissue of patients
with aneurysmal disease compared with controls, whereas
there was no difference in the pulp skin blood flow. This
was due to the greater resting-state dilatation of the adipose
arterioles of patients with aneurysms. Because arterioles of
the adipose tissue, and not AV shunts of glabrous pulp skin,
have numerous elastic fibers, they concluded that aneurys-
mal disease must have a peripheral microvascular disorder
of arteriolar elastin.
Venous insufficiency. Few studies have examined the
microcirculation in venous insufficiency. Using TCpO2,
Mani et al45 showed that oxygen tension was significantly
lower in the ulcer edge compared with the proximal portion
of the lower extremity. The nonspecific nature of TCpO2
precluded localization of the dysfunction.
More recent studies using iontophoresis and laser
Doppler fluxmetry have shown microcirculatory dysfunc-
tion specifically in the gaiter area of patients with venous
insufficiency. Endothelium-dependent vasoreactivity is im-
paired in the upright position in patients with venous
insufficiency compared with healthy controls.46 They con-
cluded that iontophoresis could be used to identify patients
with uncomplicated venous insufficiency at risk for ulcer
formation.
Dynamic capillaroscopic studies have shown that capil-
lary density, morphologic characteristics, and TCpO2 were
still normal in mild forms of venous insufficiency.47 Fluo-
rescent light intensity was significantly altered, thus indicat-
ing increased transcapillary leakage of the capillaries in the
early stage of the disease. As insufficiency worsened, there
were more capillary thromboses and increased tortuosity of
the remaining capillaries. Other studies have found similar
results, with decreased capillary density and increased con-
volutions in higher CEAP clinical stages.48
Estrogens. Estrogens have beneficial effects on the
cardiovascular system, including improvements in lipid
profile, cardiac inotropic effects, and modulation of the
stress response. These effects are, in part, related to changes
in prostaglandin levels.
We compared the microvascular vasoreactivity among
premenopausal women, postmenopausal women, and
postmenopausal women taking hormone replacement ther-
apy.49 The average serum estrogen was significantly less in
the postmenopausal group and did not differ between the
premenopausal group and postmenopausal group receiving
hormone replacement therapy. Endothelium-dependent
and -independent vasoreactivity was impaired in the post-
menopausal group compared with the other two groups.
Estrogen hormone-replacement therapy improves the
lipoprotein profile, increases vasodilatation, and inhibits
platelet aggregation and vascular smooth muscle prolifera-
tion.50,51 We found that both menopausal status and type 2
diabetes impaired endothelium-dependent and -indepen-
dent vasoreactivity compared with healthy controls. Fur-
ther, hormone replacement therapy significantly improvedmicrovascular vasoreactivity in healthy postmenopausal
women, but not in those with type 2 diabetes.52
The cyclooxygenase 2 pathway plays a specific role in
the rapid estrogen-induced potentiation of cholinergic va-
sodilatation in postmenopausal women.53 Using a double-
blind placebo-controlled design, Calkin et al assessed fore-
arm vasoreactivity in 32 healthy postmenopausal women by
using iontophoresis before and after 6-week treatment
periods with aspirin or diclofenac (both nonspecific cyclo-
oxygenase inhibitors), celecoxib (a cyclooxygenase 2 inhib-
itor), or placebo. Acute estrogen administration enhanced
the response to acetylcholine after aspirin, diclofenac, and
placebo; however, this effect was completely abolished with
celecoxib treatment. There were no changes in endothe-
lium-independent vasoreactivity.
Activity/obesity. Regular exercise results in improve-
ments to the cardiovascular system that augment blood
flow to exercising organs.54 Kvernmo et al55 compared
iontophoresis in long-distance runners and healthy con-
trols. They showed that endothelium-dependent vasoreac-
tivity was better in long distance runners at rest but that this
difference was abolished after an exercise test at 80% of their
maximal oxygen uptake. They concluded that exercise had
a beneficial effect on the endothelium-dependent vasoreac-
tivity of controls.
Obesity is associated with an increased risk of develop-
ing hypertension, insulin resistance, and microangiopathy.56
de Jongh et al56 compared vasoreactivity between obese
and lean women and found impairment of endothelium-
dependent vasoreactivity in the obese patients. Moreover,
microvascular dysfunction was associated with decreased
insulin sensitivity and increased blood pressure in both
groups.
Age. Age is a major risk factor for the pathogenesis of
vascular disease, and advancing age is associatedwith impaired
arterial elasticity and endothelial function. Both Tao et al57
and Taddei et al58 showed in separate studies that endotheli-
um-dependent vasoreactivity was decreased in the elderly
compared with young disease-matched controls. There were
no differences in endothelium-independent vasoreactivity.
Studies in experimental models suggest that this may be
due to the reduction of endothelium-derived nitric oxide
associated with aging.59 Gerhard et al59 found that endo-
thelium-dependent vasodilatation was impaired by the
fourth decade of life and progressively declined with in-
creasing age. Endothelium-independent vasodilatation did
not change with age. Although age, total cholesterol, and
low-density lipoprotein cholesterol were all univariate pre-
dictors of endothelium-dependent vasodilatation, only age
was significant by multiple stepwise regression analysis.
Finally, exercise can improve age-related changes to the
endothelium. Wang et al60 showed that exercise five times
per week was associated with improved endothelium-
dependent vasoreactivity in elderly Chinese men.
Smoking. Cigarette smoking is an independent risk
factor for PVD. Cigarette smoke contains free radicals that
degrade nitric oxide to peroxynitrate anions and lead to a
decrease in prostacyclin. Pellaton et al61 examined the
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them with age-matched controls. The smokers were asked
to smoke a cigarette just before iontophoresis. They found
that both endothelium-dependent and -independent vaso-
reactivity were impaired in older, chronic smokers com-
pared with their age-matched controls. There was no dif-
ference between young smokers and nonsmokers.
Others have found similar results. Jacobs et al62 showed
that habitual smoking in young smokers was not associated
with impairment of either endothelium-dependent or
-independent forearm venous occlusion plethysmography.
This may be due to an initial increase in the sensitivity of the
vascular smooth muscle to vasodilator stimuli due to ciga-
rette smoking.63 Treatment with antioxidants such as tet-
rahydrobiopterin64 or vitamin C65 markedly improves
endothelium-dependent responses in chronic smokers and
supports the concept that endothelial dysfunction in
chronic smokers is, at least in part, mediated by enhanced
formation of oxygen-derived free radicals.
CLINICAL APPLICATIONS
Evaluation of the microcirculation has, until now, been
used mostly for research purposes. However, abnormalities
of microcirculatory function in different disease states pro-
vide new avenues for exploration, especially as these meth-
ods become more widely available.
The techniques described previously allow physicians
to examine both the structure and function of the micro-
circulation. Currently, peripheral vascular surgery is a spe-
cialty that treats patients after the onset of symptoms.
Diagnosis of poor skin perfusion is now possible long
before the appearance of claudication, rest pain, or tissue
breakdown. Moreover, these techniques are able to specif-
ically localize the problem. Examination of the microcircu-
lation and identification of its dysfunction in patients with
multiple cardiovascular risk factors may show that they
benefit from early treatment for the prevention of PVD.
As discussed previously, these techniques provide a
noninvasive means of evaluating both medical and surgical
treatment. In the near future, the outcome of medical
treatment for diabetes mellitus or hypercholesterolemia
may be improvement of microcirculatory function and
normalization of specific serum markers.
Diagnosis of microcirculatory dysfunction may also
provide an explanation for the signs and symptoms of PVD
in the absence of poor macrocirculatory inflow or poor
outcome despite surgical revascularization. Techniques for
the evaluation of the microcirculation thus expand the
armamentarium of the vascular surgeon.
In conclusion, microcirculatory dysfunction is associ-
ated with many cardiovascular disease states and seems to
occur long before the onset of clinical symptoms. Identifi-
cation of this dysfunction with noninvasive testing may
enable clinicians to identify those at increased risk for
peripheral and cardiovascular disease. It may also allow for
the quantification andmonitoring of treatment designed to
prevent or improve microcirculatory function.REFERENCES
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